Adaptive Biotechnologies ADPT Operating margin

Operating margin at other companies

Biodesix, Inc.BDSX

-20%-7.1pp

Guardant HealthGH

-41.4%-9.4pp

Natera, Inc.NTRA

-10.7%-2.4pp

GeneDx HoldingsWGS

-14.9%—

Personalis, Inc.PSNL

-158.9%-5,457pp

Myriad GeneticsMYGN

-46.9%-88.3pp

FAQ

What is Adaptive Biotechnologies's operating margin?

Adaptive Biotechnologies (ADPT) reported operating margin of -15.8% in Q1 2026.

How has Adaptive Biotechnologies's operating margin changed year-over-year?

Adaptive Biotechnologies's operating margin increased by 79.1% year-over-year, from -75.7% to -15.8%.

What is the long-term trend for Adaptive Biotechnologies's operating margin?

Over 5 years (2020 to 2025), Adaptive Biotechnologies's operating margin has grown at a -33.2% compound annual growth rate (CAGR), from -155.3% to -20.6%.

What does operating margin mean?

Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.